EQL Pharma
Fårö Capital divests further EQL shares to enable increased institutional ownership and create more liquidity in the share
Fårö has today sold 1 million shares to an institutional buyer base and after the sale owns 7,427 million shares corresponding to 25,5 % of the shares and capital.
Datum | 2023-06-14, kl 10:10 |
Källa | Cision |

Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.